Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-25 @ 9:21 PM
Study NCT ID:
NCT03400956
Status:
TERMINATED
Last Update Posted:
2022-06-30
First Post:
2018-01-05
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids (ASTEROID 4)
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-01-24
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2018-01-05
First Submit QC Date:
None
Study First Post Date:
2018-01-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-03-24
Results First Submit QC Date:
None
Results First Post Date:
2021-04-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-04-06
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-06-29
Last Update Post Date:
2022-06-30
Last Update Post Date Type:
ACTUAL